-

Beasley Allen/Arnold & Itkin Law Firms: On Eve of J&J Bankruptcy Dismissal, Cancer Victims Prepare to Enter Civil Court System

Current claims now number 50,000

TRENTON, N.J.--(BUSINESS WIRE)--Cancer victims who are seeking to hold Johnson & Johnson (NYSE: JNJ) responsible after being exposed to cancer-causing talc in its Johnson’s Baby Powder will be asking state courts and the judge in the federal talc multidistrict litigation to immediately resume civil court trials.

“The bankruptcy that was rejected by the U.S. Court of Appeals for the Third Circuit exposed J&J’s lack of seriousness about resolving claims on a ‘fair and equitable basis,’” says Andy Birchfield, head of the Mass Tort Section at the Beasley Allen Law Firm, which represents thousands of victims with ovarian cancer claims against the company. “Any resolution must acknowledge that in the average tragedy caused by talc, a victim is facing more than $500,000 in medical costs and lost wages.”

Plaintiff attorneys report that the number of total cases has grown since J&J first attempted its now discredited “Texas Two-Step" legal maneuver. “There are close to 50,000 current claims that could easily be resolved if Johnson & Johnson would stop playing games and abusing the bankruptcy court process,” says Birchfield. “In addition, any resolution must factor in at least 20,000 future claims. This represents the ongoing damage caused by Johnson & Johnson.”

Plaintiff attorneys vow that they will fight any attempt by Johnson & Johnson to return to the bankruptcy courts.

“The appellate court was crystal clear after examining J&J’s tactics: Bankruptcy means bad faith,” says Jason Itkin, a founding partner of Houston-based Arnold & Itkin. Mr. Itkin predicts that any effort by J&J to advertise a settlement as part of a renewed bankruptcy is destined to fail. “Johnson & Johnson wouldn’t have the required 75% vote now and will never have the votes,” says Mr. Itkin. “J&J set aside $61.5 billion in its first bad-faith bankruptcy. We believe J&J is still determined to try to convince cancer victims to accept a low-ball deal that does not even pay for medical bills or wages lost due to illness. Our clients look forward to having their cases decided by a jury of their peers.”

About Beasley Allen Law Firm

Headquartered in Montgomery, Alabama, Beasley Allen is comprised of more than 70 attorneys and 200 support staff. One of the largest plaintiff law firms in the country, Beasley Allen is a national leader in civil litigation, with verdicts and settlements in excess of $26 billion. Beasley Allen was one of only 12 firms in the nation named by Law360 to its Most Feared Plaintiffs Firms list in 2015, and the firm was included on the National Law Journal Midsize Law Firm Hot List and the NLJ Elite Trial Lawyers List in 2014. For more information, visit www.beasleyallen.com.

About Arnold & Itkin LLP

Arnold & Itkin is a trial law firm based in Houston that exclusively represents plaintiffs. Founded in 2004, the firm has won cases against household names like Johnson & Johnson, BP, Shell, and numerous others. The total amount from their verdicts and settlements exceeds $10 billion, including a record-setting $222 million verdict last year for a woman who lost her husband in an industrial accident. The firm is also involved in various charitable causes in the Houston area, most notably The Monarch School & Institute, a school for learners with neurological differences. Learn more about Arnold & Itkin at www.arnolditkin.com.

Contacts

Mike Androvett
800-559-4534
mike@androvett.com

Beasley Allen Law Firm and Arnold & Itkin LLP


Release Versions

Contacts

Mike Androvett
800-559-4534
mike@androvett.com

More News From Beasley Allen Law Firm and Arnold & Itkin LLP

FDA Panel Reiterates the Cancer Risks of Talc

WASHINGTON--(BUSINESS WIRE)--A panel of medical experts convened by the U.S. Food & Drug Administration urged the agency to study and adopt new standards to prohibit the use of talc in consumer products such as gum, candy, rice and pharmaceuticals. Many of the experts cited the more than 30 years of studies showing an association between talc use and ovarian cancer, which led Johnson & Johnson (NYSE:JNJ) to remove the company’s iconic body powders from the market in recent years. “It’s...

Federal Judge Rejects Johnson & Johnson Bankruptcy Strategy, Paving Way for Talc Victims to Seek Justice in Trial Courts

HOUSTON--(BUSINESS WIRE)--In a resounding victory for thousands of women who have suffered from ovarian cancer linked to Johnson & Johnson’s (NYSE:JNJ) talcum powder products, U.S. Bankruptcy Court Judge Christopher Lopez has rejected the company’s third attempt to shield itself from liability through bankruptcy. The ruling clears the way for claimants to seek speedy jury trials in state courts and through the bellwether process in multidistrict litigation (MDL). “This decision affirms what...

Attorneys Vow to Oppose J&J’s Third Bankruptcy Attempt

HOUSTON--(BUSINESS WIRE)--Attorneys representing tens of thousands of women with ovarian cancer linked to use of Johnson & Johnson (NYSE:JNJ) talc products say they will immediately seek dismissal of a pre-packaged bankruptcy that the company filed earlier today in Texas. In its filing, the New Jersey-based pharmaceutical giant claims that approximately 83% of those plaintiffs surveyed by the company have agreed to the plan’s terms, a percentage that forms the legal threshold for launching...
Back to Newsroom